Related Experiment Videos
Placental lactogen levels in rhesus isoimmunization
British Medical Journal
|March 2, 1974
Summary
Plasma levels of human placental lactogen (HPL) can predict fetal outcomes in rhesus isoimmunization. Serial HPL measurements before 26 weeks aid in managing this condition.
Area of Science:
- Maternal-fetal medicine
- Immunology
- Endocrinology
Background:
- Rhesus isoimmunization poses risks to fetal well-being.
- Accurate monitoring is crucial for managing affected pregnancies.
Purpose of the Study:
- To evaluate plasma human placental lactogen (HPL) levels as an indicator of fetal outcome in rhesus isoimmunization.
- To determine the utility of serial HPL measurements in managing pregnancies with rhesus isoimmunization.
Main Methods:
- Prospective study design.
- Measurement of plasma human placental lactogen (HPL) levels.
- Serial monitoring of HPL levels before the 26th week of gestation.
Main Results:
- Normal HPL levels were observed in mild and moderately affected cases.
- Elevated HPL levels were detected in severely affected cases.
- Serial HPL levels before 26 weeks correlated with fetal outcome.
Conclusions:
- Plasma HPL levels are a valuable indicator in rhesus isoimmunization.
- Routine HPL estimation can supplement existing diagnostic tests.
- Early HPL monitoring aids in timely intervention and improved fetal outcomes.